We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

37 hedge funds and large institutions have $10.1M invested in Assembly Biosciences in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 38 → 37 (-1)

5.22% less ownership

Funds ownership: 28.44% → 23.21% (-5.2%)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

50% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 14

69% less capital inflows, than outflows

Capital inflows: $1.05M | Capital outflows: $3.39M

Holders
37
Holders Change
-1
Holders Change %
-2.63%
% of All Funds
0.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
7
Reduced
14
Closed
5
Calls
$53K
Puts
–
Net Calls
+$53K
Net Calls Change
+$28K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$369K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$114K
3
Two Sigma Investments
Two Sigma Investments
New York
+$53.8K
4
Citadel Advisors
Citadel Advisors
Florida
+$45.3K
5
Morgan Stanley
Morgan Stanley
New York
+$18.3K

Top Sellers

Rank Fund Capital Flow
1
Deep Track Capital
Deep Track Capital
Connecticut
-$2.38M
2
PIM
Platinum Investment Management
Australia
-$287K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$140K
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$105K
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$85K

ASMB Hedge Fund Activity: Q1 2023 in Review

37 of the 6,288 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2023, worth a combined $10.1M — down 44% from $18M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ASMB and 4 opened new positions — a net loss of 1 holder — while 14 trimmed existing stakes and 7 added.

The largest buyer was Renaissance Technologies, adding an estimated $369K. The largest seller was Deep Track Capital, exiting entirely with an estimated $2.38M sold.

  • 37 institutional investors held Assembly Biosciences (ASMB) as of Q1 2023, down from 38 in Q4 2022.
  • Funds reported $10.1M of Assembly Biosciences stock for Q1 2023, down 44% quarter-over-quarter.
  • 4 funds opened new Assembly Biosciences positions in Q1 2023 and 5 closed out, a net change of -1 holder.
  • The largest Assembly Biosciences buyer in Q1 2023 was Renaissance Technologies, an estimated $369K added.
  • The largest Assembly Biosciences seller in Q1 2023 was Deep Track Capital, an estimated $2.38M sold.

Based on aggregated 13F filings for Q1 2023.